T1	Participants 60 73	heart failure
T2	Participants 221 242	chronic heart failure
T3	Participants 748 814	symptomatic patients with heart failure on optimal medical therapy
T4	Participants 885 911	650 patients from 80 sites
T5	Participants 1025 1208	Inclusion criteria include left ventricular systolic dysfunction, the presence of New York Heart Association Class III symptoms, sinus rhythm, and QRS width less than 120 milliseconds
